Cited by 87Atrial Fibrillation Management and OutcomesCardiovascular and exercise physiologyHeart rate and cardiovascular health

Calcium channel blockers improve exercise capacity and reduce N-terminal Pro-B-type natriuretic peptide levels compared with beta-blockers in patients with permanent atrial fibrillation

Ulimoen, Sara R., Enger, Steve, Pripp, Are Hugo, Abdelnoor, Michael, Arnesen, Harald, Gjesdal, Knut, Tveit, Arnljot·2014·European Heart Journal

Abstract

AIMS: Rate control of atrial fibrillation (AF) has become a main treatment modality, but we need more knowledge regarding the different drugs used for this purpose. In this study, we aimed to compare the effect of four common rate-reducing drugs on exercise capacity and levels of N-terminal pro-B-type natriuretic peptide (NT-proBNP) in patients with permanent AF. METHODS AND RESULTS: We included 60 patients (mean age 71 ± 9 years, 18 women) with permanent AF and normal left ventricular function in a randomized, cross-over, investigator-blind study. Diltiazem 360 mg, verapamil 240 mg, metoprolol 100 mg, and carvedilol 25 mg were administered o.d. for 3 weeks. At baseline and on the last day of each treatment period, the patients underwent a maximal cardiopulmonary exercise test and blood samples were obtained at rest and at peak exercise. The exercise capacity (peak VO2) was significantly lower during treatment with metoprolol and carvedilol compared with baseline (no treatment) or treatment with diltiazem and verapamil (P < 0.001 for all). Compared with baseline, treatment with diltiazem and verapamil significantly reduced the NT-proBNP levels both at rest and at peak exercise, whereas treatment with metoprolol and carvedilol increased the levels (P < 0.05 for all). CONCLUSION: Rate-reducing treatment with diltiazem or verapamil preserved exercise capacity and reduced levels of NT-proBNP compared with baseline, whereas treatment with metoprolol or carvedilol reduced the exercise capacity and increased levels of NT-proBNP.

Integrity signals

Registry

Crossref · 10.1093/eurheartj/eht429

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In one small trial of low-risk patients with preserved LVEF, beta-blockers reduced exercise capacity and increased B-type natriuretic peptide.

    “Verapamil or diltiazem can improve arrhythmia-related symptoms, 526 in comparison with beta-blockers, which reduced exercise capacity and increased B-type natriuretic peptide in one small trial of low-risk patients with preserved LVEF.542”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ulimoen, S. R., Enger, S., Pripp, A. H., Abdelnoor, M., Arnesen, H., Gjesdal, K., & Tveit, A.
Affiliations
  • Vestre Viken Hospital Trust (NO)
  • Oslo University Hospital (NO)
Corresponding author
Ulimoen, Sara R.
Venue
European Heart Journal
Published
2013-10-17
Volume
35
Issue
8
Pages
517-524
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W2137768025
Cited by
87
References
57
Citations by year
2026: 5 · 2025: 11 · 2024: 15 · 2023: 3 · 2022: 6 · 2021: 3 · 2020: 9 · 2019: 3 · 2018: 7 · 2017: 5 · 2016: 8 · 2015: 5 · 2014: 5 · 2013: 1
FWCI
4.31
Type
journal article
Language
en
Open access
closed
Locations
  • European Heart Journal (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
  • Health Sciences › Medicine › Complementary and alternative medicine › Cardiovascular and exercise physiology
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
Keywords
permanent atrial fibrillation, calcium channel blockers, beta-blockers, rate control, exercise capacity, N-terminal pro-brain natriuretic peptide, diltiazem, verapamil, metoprolol, carvedilol, cardiopulmonary exercise testing, peak oxygen uptake
MeSH terms
Carvedilol, Adrenergic beta-Antagonists, Aged, Atrial Fibrillation, Calcium Channel Blockers, Carbazoles, Delayed-Action Preparations, Diltiazem, Female, Humans, Male, Metoprolol, Oxygen Consumption, Peptide Fragments, Propanolamines, Prospective Studies, Verapamil, Exercise Tolerance, Cross-Over Studies, Natriuretic Peptide, Brain

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review